Table 3 Summary of the longitudinal studies with altered short-term BPV and association with CKD progression
From: Short-term blood pressure variability as a potential therapeutic target for kidney disease
Study | Study subject | No. of subjects | Indices of BPV | Type of association | Outcome |
|---|---|---|---|---|---|
Agarwal et al. [66] | With/without CKD | 217 | Nondipping | Indifferent | ESKD |
Agarwal et al. [65] | CKD | 322 | Nondipping | Indifferent | ESKD |
Borrelli et al. [71] | CKD | 906 | Nondipping | Positive | Initiation of dialysis or eGFR decline ≥ 50% |
Davidson et al. [72] | CKD | 322 | Nondipping | Positive | Rapid decline in eGFR |
Ida et al. [68] | CKD | 1,107 | Nondipping | Indifferent | Initiation of RRT or eGFR decline ≥ 40% |
Liu et al. [75] | CKD | 304 | MBPS | Positive | ESKD or eGFR decline ≥ 50% |
Borrelli et al.[20] | CKD | 465 | wSD and CV | Indifferent | ESKD or eGFR decline ≥ 50% |
Jhee et al. [73] | CKD | 470 | ARV | Positive | Rapid kidney function declinea) |
Rahman et al. [70] | CKD | 1,502 | Nondipping or reverse dipping | Positive | ESKD or eGFR decline ≥ 50% |
Redon et al. [67] | CKD | 79 | Nondipping | Indifferent | Rapid decline in eGFRa) |
Wang et al. [69] | CKD | 588 | Reverse dipping | Positive | ESKD or doubling of serum creatinine |
Wang et al. [74] | CKD | 1,421 | wSD | Positive | ESKD |